Antigen Preparation
A recombinant protein of HPV type 16 protein.
Background
"The infection with certain typse of HPV, the so called ""oncogenic HPV's"" including 16, 18, 31, 33 and 35, has been associated as a major risk factor in the subsequent development of cervical cancer. The high-risk HPV 16 group is almost equally associated with the cervical intraepithelial neoplasia (CIN) and cervical cancer. HPV 6 and 11 are found mainly in benign cervical lesions while HPV 16 and 18 have been associated with premalignant and malignant cervical lesions. The presence of HPV has been reported in malignant lesions of skin, oral cavity, tongue and lung. This antibody Papillomavirus type 16 in the nucleus of infected cells or tissues stained by immunohistochemical techniques."
Applications/Suggested Working Dilutions
|
|
|
Immunoprecipitation
2-5 µg/ml
|
|
Flow cytometry
Not tested
|